SUPREME COURT SEEKS ADMINISTRATION'S OPINION ON IDE APPROVAL PREEMPTION OVER TORT CLAIMS; IOLAB PETITION QUESTIONS APPLICABILITY OF MEDTRONIC V. LOHR
This article was originally published in The Gray Sheet
Executive Summary
The Administration is expected to file in 60-90 days its opinion on whether FDA's Investigational Device Exemption regulation preempts state tort claims in response to a case before the U.S. Supreme Court.
You may also be interested in...
Supreme Court Seeks Solicitor General’s Input On PMA Preemption
The U.S. Supreme Court is considering whether to hear a potentially far-reaching case on whether patients injured by PMA-approved devices can sue manufacturers under state laws
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.